We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Alzheimer's detected before symptoms via new eye technology
News

Alzheimer's detected before symptoms via new eye technology

Alzheimer's detected before symptoms via new eye technology
News

Alzheimer's detected before symptoms via new eye technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Alzheimer's detected before symptoms via new eye technology "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Human clinical trials scheduled -


Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe—in the back of the eye—progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science (IOVS).


The paper builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer's.


See Also: Researchers develop blood test that detects early Alzheimer's disease


Early detection of Alzheimer's is critical for two reasons. "First, effective treatments need to be administered well before patients show actual neurological signs," said author Robert Vince, PhD, of the Center for Drug Design at the University of Minnesota (UMN). "Second, since there are no available early detection techniques, drugs currently cannot be tested to determine if they are effective against early Alzheimer's disease. An early diagnostic tool like ours could help the development of drugs as well."


Looking through the eye to see the brain is a key advantage of the new technology. "The retina of the eye is not just 'connected' to the brain—it is part of the central nervous system," said author Swati More, PhD, also of the Center for Drug Design at UMN. While the brain and retina undergo similar changes due to Alzheimer's disease, "unlike the brain, the retina is easily accessible to us, making changes in the retina easier to observe."


Don't Miss: Odor biomarker for Alzheimer’s disease


"We saw changes in the retinas of Alzheimer's mice before the typical age at which neurological signs are observed," said More. "The results are close to our best-case scenario for outcomes of this project."


For more information on participating in the clinical trial, please visit the trial website.


Note: Material may have been edited for length and content. For further information, please contact the cited source.


Association for Research in Vision and Ophthalmology   press release


Publication

More SS, Beach JM, Vince R. Early Detection of Amyloidopathy in Alzheimer's Mice by Hyperspectral Endoscopy.   Investigative Ophthalmology & Visual Science, Published June 2016. doi: 10.1167/iovs.15-17406


Advertisement